CORC  > 山东大学
Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis
Wang Y.; Qu X.; Shen H.-C.; Wang K.; Liu Q.; Du J.-J.
刊名Asian Pacific Journal of Cancer Prevention
2015
卷号16期号:11页码:4759-4768
关键词Anti-EGFR agents Hung cancer K-ras mutation Loss of PTEN PIK3CA mutation
DOI10.7314/APJCP.2015.16.11.4759
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4789207
专题山东大学
作者单位1.Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, China
2.Institute
推荐引用方式
GB/T 7714
Wang Y.,Qu X.,Shen H.-C.,et al. Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis[J]. Asian Pacific Journal of Cancer Prevention,2015,16(11):4759-4768.
APA Wang Y.,Qu X.,Shen H.-C.,Wang K.,Liu Q.,&Du J.-J..(2015).Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis.Asian Pacific Journal of Cancer Prevention,16(11),4759-4768.
MLA Wang Y.,et al."Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis".Asian Pacific Journal of Cancer Prevention 16.11(2015):4759-4768.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace